Go to content
|
Navigation
|
Direct access
|
Connection
Menu
News
Directory
Events diary
Contact
Members access
ENT
Annuaire
Intranet
Editic
INSERM Clé
Search
Search
EN
français
English
U1253 Imagerie & Cerveau
News
News
News
General public
Students
Scientifics
Directory
Events diary
Contact
Members access
ENT
Annuaire
Intranet
Editic
INSERM Clé
Home
Research topics
Neuro‐functional Psychiatry
Neuro‐functional Psychiatry
Autism
Depression
Neurogenomics and Neuronal Physiopathology
Imaging, Biomarkers and Therapy
About Us
Our objectives
Funded projects
Share
Print
Share
Facebook
Twitter
Linkedin
Ecouter
News
You are here :
English version
News
General public
[PRESS RELEASE] GE heatlthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical
Dates
from April 10, 2022 to May 1, 2022
Contact :
Maria-Joao Santiago-Ribeiro :
maria.ribeiro@univ-tours.fr
Learn more
[MEDIA] A Tours, la chaire Unesco dédiée fait référence
[The Conversation] Pour sa santé mentale et son bien-être, quelles activités sportives privilégier ?
[The Conversation] Maltraitance infantile : Comment la violence actuelle induit la violence future
Top of the page
https://ibrain.univ-tours.fr/english-version/news/general-public/communique-de-presse-ge-heatlthcare-annonce-le-debut-de-letude-de-phase-iii-pour-le-medicament-radiopharmaceutique-18f-lbt